Different impact of excision repair cross-complementation group 1 on survival in male and female patients with inoperable non-small-cell lung cancer treated with carboplatin and gemcitabine.

Source:http://linkedlifedata.com/resource/pubmed/id/19667277

J. Clin. Oncol. 2009 Sep 10 27 26 4254-9

Download in:

View as

General Info

PMID
19667277